CClinicalTrials.gg
CompletedNCT02484651Updated Sep 16, 2019Results posted

Can Adequacy of Anesthesia Depth and Quality of Recovery be Influenced by the Level of Neuromuscular Blockade?

A Phase 4 interventional study of Sugammadex and Rocuronium in Neuromuscular Block, sponsored by Centro Hospitalar do Porto. Completed at 1 site in Portugal. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2019-09-16.

Sponsored by Centro Hospitalar do Porto · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The investigators hypothesize that an anesthetic protocol maintaining deep neuromuscular block throughout the entire surgical procedure followed by sugammadex reversal, would suppress EMG activity and result in improved anesthetic stability by reducing the variability of the Bispectral Index of the EEG, and be beneficial by reducing the total doses of the anesthetic drugs propofol and remifentanil required to maintain an adequate level of anesthesia (BIS between 40 and 60).

02

Conditions studied

  • Neuromuscular Block

Keywords

  • deep neuromuscular block
  • sugammadex
  • stability of anesthesia
  • suppression of EMG activity
  • PQRS
  • General Anesthesia
  • Quality of Recovery
03

In context

Lead sponsor

Centro Hospitalar do Porto is the lead sponsor of 16 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients ASA I-III
  • Between 18 - 80 years old
  • Scheduled for routine cervical surgery
  • Minimum duration of surgery is 90 minutes and performed with total intravenous anaesthesia (TIVA) with the hypnotic propofol, the analgesic remifentanil and the neuromuscular relaxant rocuronium
  • Patients that are able to and do provide a signed informed consent form

Exclusion criteria

Exclusion Criteria:

  • Patients with neuromuscular diseases and severe cardiac and respiratory pathologies
  • Contra indication for any of the drugs used
  • Not able to complete the baseline PQRS test.
  • Indication to perform tracheal intubation using fibroscopy
  • Patients who are pregnant or nursing
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (actual)

Study arms

  • No intervention
    Standard Group

    Standard Clinical Practice Group - standard neuromuscular block, with a standard rocuronium dose for intubation (0.6 mg/kg). If required, the reversal of neuromuscular block is performed with neostigmine.

  • Experimental
    Deep NMB group

    Deep Neuromuscular Block group - with a standard rocuronium dose for intubation (0.6 mg/kg), followed by a constant infusion of rocuronium (10-15 ug/kg/min) to guarantee a PTC less or equal to 2 on the TOF monitor (PTC is evaluated every 5 minutes). The reversal of neuromuscular block is performed with Sugammadex (4 mg/kg).

    Drug: Sugammadex · Drug: Rocuronium

Interventions

  • DrugSugammadex

    Reversal of deep neuromuscular block

    Also known as: Org 25969, Bridion

  • DrugRocuronium

    Maintenance of deep neuromuscular block

    Also known as: Zemuron, Esmeron

06

What researchers measure

Primary outcomes

  1. BIS Signal Variability Using the Measured Standard Deviation During the Maintenance Phase of Anesthesia

    BIS (Bispetral Index of the EEG) sample standard deviation during the maintenance phase of anesthesia was used as a measure of signal variability, maintenance phase is defined as the time between the first time the BIS signal drops below 60 after loss of consciousness, until the time the BIS signal goes above 60 after the propofol infusion is stopped. BIS signal varies between 0 to 100. BIS values near 100 represent an "awake" clinical state while 0 denotes the maximal effect an isoelectric EEG. The aim was to maintain the BIS value within a target range of 40 to 60. The higher the BIS sample standard deviation the higher the oscillation around the sample mean.

    Time frame: Maintenance of anesthesia, an average of 130 minutes

  2. Required Effect-site Concentrations of Propofol and Remifentanil

    Mean effect-site concentration of propofol required during maintenance of anesthesia (using target controlled infusion). Mean effect-site concentration of remifentanil required during maintenance of anesthesia (using target controlled infusion).

    Time frame: Maintenance of anesthesia, an average of 130 minutes

Secondary outcomes

  1. PQRS Results at 15 and 40 Minutes After Surgery (Taking Into Account the Patient Baseline Values of the PQRS Test Done on the Preanesthetic Visit)

    PQRS(Post-operative Quality Recovery Scale) recovery rate at 15 minutes post surgery and PQRS recovery rate at 40 minutes post surgery. Recovery is defined as returning to PQRS baseline values.

    Time frame: 15 and 40 minutes after surgery

  2. PQRS Satisfaction Results at Day 3 After Surgery

    Patient satisfaction with anesthetic care rated as: Not satisfied, A little satisfied, Moderately satisfied ,Satisfied, Totally Satisfied

    Time frame: 3rd day after surgery

07

Results

Posted Sep 16, 2019

Participant flow

Recruitment started on the 2016/9/19 and finished on 2017/6/28 at Centro Hospitalar do Porto, Portugal.

Participant flow — Overall Study
MilestoneStandard GroupDeep NMB Group
Started3535
End of clinical study3535
Data analysis3231
Completed3231
Not completed34
Withdrew: Patients' data files were corrupted.11
Withdrew: Bis monitoring failed.11
Withdrew: Time of the procedure less than 90 min.12

Outcome measures

PrimaryBIS Signal Variability Using the Measured Standard Deviation During the Maintenance Phase of Anesthesia

BIS (Bispetral Index of the EEG) sample standard deviation during the maintenance phase of anesthesia was used as a measure of signal variability, maintenance phase is defined as the time between the first time the BIS signal drops below 60 after loss of consciousness, until the time the BIS signal goes above 60 after the propofol infusion is stopped. BIS signal varies between 0 to 100. BIS values near 100 represent an "awake" clinical state while 0 denotes the maximal effect an isoelectric EEG. The aim was to maintain the BIS value within a target range of 40 to 60. The higher the BIS sample standard deviation the higher the oscillation around the sample mean.

Time frame:
Maintenance of anesthesia, an average of 130 minutes
Reported as:
Mean · units on a scale
BIS Signal Variability Using the Measured Standard Deviation During the Maintenance Phase of Anesthesia
units on a scaleStandard GroupDeep NMB Group
BIS Signal Variability Using the Measured Standard Deviation During the Maintenance Phase of Anesthesia7.6 ± 1.67.8 ± 1.6
Statistical analysis
  • Standard Group vs Deep NMB Group · t-test, 2 sided · p = 0.651
PrimaryRequired Effect-site Concentrations of Propofol and Remifentanil

Mean effect-site concentration of propofol required during maintenance of anesthesia (using target controlled infusion). Mean effect-site concentration of remifentanil required during maintenance of anesthesia (using target controlled infusion).

Time frame:
Maintenance of anesthesia, an average of 130 minutes
Reported as:
Mean · ng/ml
Required Effect-site Concentrations of Propofol and Remifentanil
ng/mlStandard GroupDeep NMB Group
Propofol3000 ± 5602450 ± 550
Remifentanil3.26 ± 1.022.84 ± 1.12
Statistical analysis
  • Standard Group vs Deep NMB Group · t-test, 2 sided · p = <0.001
  • Standard Group vs Deep NMB Group · t-test, 2 sided · p = 0.245
SecondaryPQRS Results at 15 and 40 Minutes After Surgery (Taking Into Account the Patient Baseline Values of the PQRS Test Done on the Preanesthetic Visit)

PQRS(Post-operative Quality Recovery Scale) recovery rate at 15 minutes post surgery and PQRS recovery rate at 40 minutes post surgery. Recovery is defined as returning to PQRS baseline values.

Time frame:
15 and 40 minutes after surgery
Reported as:
Count of participants · Participants
PQRS Results at 15 and 40 Minutes After Surgery (Taking Into Account the Patient Baseline Values of the PQRS Test Done on the Preanesthetic Visit)
ParticipantsStandard GroupDeep NMB Group
15 minutes — Overall recovery25
15 minutes — Did not recovered2421
40 minutes — Overall recovery03
40 minutes — Did not recovered3227
Statistical analysis
  • Standard Group vs Deep NMB Group · Fisher Exact · p = 0.419
  • Standard Group vs Deep NMB Group · Fisher Exact · p = 0.107
SecondaryPQRS Satisfaction Results at Day 3 After Surgery

Patient satisfaction with anesthetic care rated as: Not satisfied, A little satisfied, Moderately satisfied ,Satisfied, Totally Satisfied

Time frame:
3rd day after surgery
Reported as:
Count of participants · Participants
PQRS Satisfaction Results at Day 3 After Surgery
ParticipantsStandard GroupDeep NMB Group
Totally satisfied2727
Satisfied32
Moderately satisfied00
A little satisfied00
Not satisfied00
Statistical analysis
  • Standard Group vs Deep NMB Group · Chi-squared · p = 0.669

Adverse events

Collected over Adverse event data were collected by the researchers up to 3 days after surgery.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Standard Group0/35 (0%)0/35 (0%)2/35 (5.7%)
Deep NMB Group0/35 (0%)0/35 (0%)6/35 (17.1%)
Most frequent other events
Most frequent other events
EventStandard GroupDeep NMB Group
Emergence deliriumNervous system disorders0/352/35
Neck painSurgical and medical procedures1/350/35
Nausea and urinary retentionGeneral disorders1/350/35
TachycardiaCardiac disorders0/351/35
Post-operative hypertensionGeneral disorders0/351/35
Asystole of 20 secondsCardiac disorders0/351/35
Post-operative dyspnea and anxietySurgical and medical procedures0/351/35

Baseline characteristics

Age, Continuous
Age, Continuous(years)Standard GroupDeep NMB GroupTotal
Mean52.4 ± 10.752.6 ± 7.952.5 ± 9.3
Sex: Female, Male
Sex: Female, Male(Participants)Standard GroupDeep NMB GroupTotal
Female181735
Male141428
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Standard GroupDeep NMB GroupTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American000
White323163
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(Participants)Standard GroupDeep NMB GroupTotal
Portugal323163
Mean Arterial Pressure
Mean Arterial Pressure(mmHg)Standard GroupDeep NMB GroupTotal
Mean105.6 ± 12.8101.4 ± 12.5103.5 ± 12.7
08

Study locations

1 site
  • Centro Hospitalar do Porto
    Porto, 4099-001, Portugal
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Jan 26, 2016

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02484651
Lead sponsor
Centro Hospitalar do Porto
Collaborators
Merck Sharp & Dohme LLC
Responsible party
Pedro Amorim, MD (Pedro Amorim, MD, Centro Hospitalar do Porto) — Principal investigator
First posted
Jun 29, 2015
Start date
Sep 2016
Primary completion
Jun 28, 2017
Completion
Jul 1, 2017
Results posted
Sep 16, 2019
Last update
Sep 16, 2019

Study contacts

Pedro Amorim, MD
principal investigator · Centro Hospitalar do Porto

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion